Following surface engineering of IL-2, the resulting exosomes’ miR profiles underwent substantial changes that activated CD8 + T cells and decreased the expression of PD-L1 in melanoma cells via differentially expressed miRs [142]. This evidence concerns the gene CD8A and melanoma.